The Latest Breaking News from Cholesterol

A recent study published in the journal Gut sheds light on the complex link between serum lipids, lipid-modifying targets, and cholelithiasis, a prevalent illness marked by gallstone production. Read further on Dynamite News:

Using a CRISPR-guided technique called "base editing," scientists edited the genes of liver cells in 10 people's bodies.

Verve stock crashed Monday as safety concerns plagued its gene-editing approach to high cholesterol. VERV stock lost more than a third of its value.

Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.

Scientists have developed a structurally modified antifungal agent that retains its antimicrobial properties while reducing toxicity in mice and human kidney cells. The new compound, AM-2-19, could increase the effectiveness and safety of treatments for deadly fungal infections. It works by binding to and extracting fungal ergosterol, but not mammalian…

Omega-3s are most commonly found in fish, though you also get them from dark leafy greens, flax seeds, hemp seeds and walnuts.

Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.

Rosuvastatin found to increase risk of type 2 diabetes compared to atorvastatin, warns new research

The epidemiology of food and drink is a mess.